Cargando…
Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)(2) Containing Liposomes for the Treatment of Neuroblastoma
Preclinical in vitro studies of drug candidates for anticancer therapy are generally conducted on well-established 2D cell models. Unfortunately, these models are unable to mimic the properties of in vivo tumors. However, in vitro 3D models (spheroids) have been proven to be superior in reflecting t...
Autores principales: | Hartwig, Friederike, Köll-Weber, Monika, Süss, Regine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234124/ https://www.ncbi.nlm.nih.gov/pubmed/34204205 http://dx.doi.org/10.3390/pharmaceutics13060894 |
Ejemplares similares
-
Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids
por: Langer, Carolin, et al.
Publicado: (2022) -
Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude, Karine, et al.
Publicado: (2013) -
A Thermosensitive, Chitosan-Based Hydrogel as Delivery System for Antibacterial Liposomes to Surgical Site Infections
por: Kaul, Laurine, et al.
Publicado: (2022) -
Ddc2 Mediates Mec1 Activation through a Ddc1- or Dpb11-Independent Mechanism
por: Bandhu, Amitava, et al.
Publicado: (2014) -
Characterization data on the topical carrier DDC642
por: Desmet, Eline, et al.
Publicado: (2016)